Metabolomics is an emerging field of research associated with the characterization of metabolites in various biological systems. This branch of science offers an overview of the metabolic status and provides insights into pathological and physiological states of a biological system. Metabolites data integrated with proteomics and transcriptomics has led to innovative developments in flux analysis, informatics, and biochemical modelling. The global metabolomics market is expanding at a positive rate with the emergence of advanced analytical equipment and software solutions to assess the level of metabolites in a biological system.
Government Support Augments Growth of Global Metabolomics Market
Increasing initiatives and funding of research projects by private and government institutions have propelled the growth of the global metabolomics market. The rapid growth of the biotechnology and pharmaceutical sectors has also supported the market. However, the lack of skilled professionals in the field is expected to hamper the growth of the market in the coming years. Furthermore, the low adoption of advanced metabolomics products is likely to restrain the overall market.
HPLC Technique Dominated Global Metabolomics Market in 2015
In terms of technique, the global metabolomics market has been broadly segmented into detection and separation. Detection techniques include mass spectrometry and nuclear magnetic resonance spectroscopy (NMR). On the other hand, separation techniques have been categorized into capillary electrophoresis, gas chromatography, ultra-performance liquid chromatography (UPLC), and high-performance liquid chromatography (HPLC). HPLC, with ultraviolet detection, is the most commonly used method for the targeted analysis of plant materials. In 2015, the HPLC technique accounted for the largest share in the market. The technique is also used for the metabolic profiling of individual classes of compounds.
On the basis of application, the global metabolomics market has been divided into nutrigenomics, biomarker discovery, drug assessment, clinical toxicology, and others. The growing demand for metabolomics for drug assessment and biomarker discovery is expected to define the future of the market.
Key Regions in Global Metabolomics Market
The key regions in the global metabolomics market are Europe, Asia Pacific, North America, the Middle East and Africa, and Latin America. In the developed countries across Europe and North America, government support in the form of research grants has played an important role in the growth of the market. In the U.S., regular workshops and extensive research activities funded by the National Institutes of Health (NIH) have contributed significantly towards the growth of the regional metabolomics market. Understanding the importance of metabolomics in the field of drug discovery, the NIH has started a Common Fund Metabolomics Initiative.
Browse Full Global Metabolomics Market Report with TOC:http://www.mrrse.com/metabolomics-market
Major Players in Global Metabolomics Market Collaborating with Research Institutes
Some of the major players in the global metabolomics market are Shimadzu Corporation (Japan), Agilent Technologies, Inc. (U.S.), LECO Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), Bio-Rad Laboratories, Inc.(U.S.), Waters Corporation (U.S.), Metabolon, Inc. (U.S.), and Bruker Corporation (U.S.). The key players are focusing on collaborations with various universities in order to develop new tools and techniques to understand the impact of the various metabolites present in the body.